Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Fatostatin hydrobromide
Cat. No.:
OB0225LY-0004
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Fatostatin hydrobromide is a specific inhibitor of SREBP activation, which plays a critical role in lipid metabolism and cell proliferation.
Synonym:
Fatostatin HBr; Fatostatin A; Fatostatin A HBr; Fatostatin; 298197-04-3; 2-(2-Propylpyridin-4-yl)-4-(p-tolyl)thiazole hydrobromide; 2-Propyl-4-(4-p-tolyl-thiazol-2-yl)-pyridine; 4-[4-(4-methylphenyl)-2-thiazolyl]-2-propyl-pyridine, hydrobromide; 4-(4-Methylphenyl)-2-(2-propylpyridin-4-yl)-1,3-thiazole; hydrobromide
CAS No.:
298197-04-3
Compound CID:
2850562
Formula:
C18H18N2S·HBr
Formula Weight:
375.33
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Fatostatin hydrobromide can be used as an SREBP inhibitor in metabolic research and anti-tumor studies.
Library Information
Targets:
Fatty acid synthesis; NPC1L1
Receptors:
Fatty acid synthase; SREBPs
Pathways:
Membrane transporter/Ion channel; Metabolism
Plate Number:
AOCL-1
Plate Location:
a5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
3.75 mg/mL; 10 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
58 mg/mL; 154.53 mM
ALogP:
5.389
HBA_Count:
2
HBD_Count:
0
Rotatable Bond:
4
